NatureWise Biotech & Medicals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
NatureWise Biotech & Medicals has a total shareholder equity of NT$641.9M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$700.9M and NT$59.0M respectively. NatureWise Biotech & Medicals's EBIT is NT$8.0M making its interest coverage ratio -1.3. It has cash and short-term investments of NT$493.9M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
NT$0
Borç
| Faiz karşılama oranı | -1.3x |
| Nakit | NT$493.91m |
| Eşitlik | NT$641.93m |
| Toplam yükümlülükler | NT$58.98m |
| Toplam varlıklar | NT$700.91m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4732's short term assets (NT$630.2M) exceed its short term liabilities (NT$50.6M).
Uzun Vadeli Yükümlülükler: 4732's short term assets (NT$630.2M) exceed its long term liabilities (NT$8.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4732 is debt free.
Borcun Azaltılması: 4732 has not had any debt for past 5 years.
Borç Kapsamı: 4732 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 4732 has no debt, therefore coverage of interest payments is not a concern.